Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag
10:51am, Thursday, 16'th Apr 2026
Shares of Abbott Laboratories (NYSE:ABT) fell 3.2% on Thursday morning after the healthcare conglomerate marginally beat Wall Street estimates for quarterly profit and revenue, but flagged a hit to it
96,685 Shares in Exact Sciences Corporation $EXAS Purchased by Capricorn Fund Managers Ltd
04:43am, Monday, 06'th Apr 2026
Capricorn Fund Managers Ltd acquired a new stake in shares of Exact Sciences Corporation (NASDAQ: EXAS) during the undefined quarter, according to its most recent disclosure with the SEC. The fund acq
Exact Sciences Corporation $EXAS Shares Sold by Exchange Traded Concepts LLC
03:52am, Saturday, 04'th Apr 2026
Exchange Traded Concepts LLC cut its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 39.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
FNY Investment Advisers LLC Buys Shares of 28,500 Exact Sciences Corporation $EXAS
05:08am, Friday, 03'rd Apr 2026
FNY Investment Advisers LLC acquired a new position in shares of Exact Sciences Corporation (NASDAQ: EXAS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchan
Banque Pictet & Cie SA Lowers Position in Exact Sciences Corporation $EXAS
03:30am, Friday, 03'rd Apr 2026
Banque Pictet and Cie SA decreased its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 77.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securitie
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
04:31pm, Tuesday, 17'th Mar 2026
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four presentations at the 2026 American Association fo
Bridgefront Capital LLC Buys Shares of 11,994 Exact Sciences Corporation $EXAS
05:28am, Monday, 16'th Mar 2026
Bridgefront Capital LLC bought a new position in Exact Sciences Corporation (NASDAQ: EXAS) in the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought
ArrowMark Colorado Holdings LLC Purchases 113,603 Shares of Exact Sciences Corporation $EXAS
03:52am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC boosted its position in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 23.5% during the undefined quarter, according to its most recent 13F filing with the Secu
Exact Sciences Corporation $EXAS Shares Bought by Dimensional Fund Advisors LP
03:45am, Thursday, 12'th Mar 2026
Dimensional Fund Advisors LP raised its position in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 12.3% in the undefined quarter, according to the company in its most recent disclosure with t
Exact Sciences (EXAS) is a Top-Ranked Momentum Stock: Should You Buy?
10:50am, Wednesday, 11'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 04'th Mar 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limited Sponsored ADR (CSLLY) and Exact Sciences (EXAS). But which of these two stocks presents investors
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
09:00am, Wednesday, 04'th Mar 2026
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Aw
WILMINGTON, Del.--(BUSINESS WIRE)-- #AIinHealthcare--Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia He
DNB Asset Management AS Raises Position in Exact Sciences Corporation $EXAS
04:50am, Sunday, 01'st Mar 2026
DNB Asset Management AS boosted its position in Exact Sciences Corporation (NASDAQ: EXAS) by 15.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities
Exact Sciences Stockholders Approve Acquisition by Abbott
04:05pm, Friday, 20'th Feb 2026
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders vot
